| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/21/2013 | US20130045237 Combination pharmaceutical composition and methods of treating and preventing the infectious diseases |
| 02/21/2013 | US20130045170 Immunity boosting gum |
| 02/21/2013 | US20130045169 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity |
| 02/21/2013 | US20130045162 Delivery system for specifically targeting cancer cells and method of use thereof |
| 02/21/2013 | US20130045160 Magnetic Nano-Composite for Contrast Agent, Intelligent Contrast Agent, Drug Delivery Agent for Simultaneous Diagnosis and Treatment, and Separation Agent for Target Substance |
| 02/21/2013 | CA2845634A1 Abuse-resistant mucoadhesive devices for delivery of buprenorphine |
| 02/21/2013 | CA2845617A1 Cardiovascular therapeutics |
| 02/21/2013 | CA2845301A1 Combinations of corroles and statins |
| 02/21/2013 | CA2845267A1 Low protein percentage gelling compositions |
| 02/21/2013 | CA2845228A1 Controlled-release formulation |
| 02/21/2013 | CA2845118A1 Steroid hormone delivery systems and methods of preparing the same |
| 02/21/2013 | CA2844944A1 Pharmaceutical aerosol product for administration by oral or nasal inhalation |
| 02/21/2013 | CA2844927A1 Vacuum-assisted preservation of biological products, in particular of vaccines |
| 02/21/2013 | CA2844907A1 Concentrated felbamate formulations for parenteral administration |
| 02/21/2013 | CA2844827A1 Use of inorganic matrix and organic polymer combinations for preparing stable amorphous dispersions |
| 02/21/2013 | CA2843881A1 Sustained release composition of prostacyclin |
| 02/21/2013 | CA2843100A1 Funny current (if) inhibitors for use in a method of treating and preventing heart failure in feline |
| 02/21/2013 | CA2841549A1 Taste masked pharmaceutical composition |
| 02/20/2013 | EP2559436A1 Composition comprising aluminum silicates and silver nanoparticles as bactericides |
| 02/20/2013 | EP2559435A1 Rotigotine in the treatment of hemispatial neglect, stroke and deficits following stroke |
| 02/20/2013 | EP2559431A1 Pharmaceutical composition comprising 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide |
| 02/20/2013 | EP2559430A1 Solubilized ibuprofen |
| 02/20/2013 | EP2559429A2 Anticancer drug delivery system using ph-sensitive metal nanoparticles |
| 02/20/2013 | EP2559428A1 Micronized opioid compositions and dosage forms and methods of making same |
| 02/20/2013 | EP2559427A1 Transdermal therapeutic system having a content of a modulator for nicotinic acetylcholine receptors (nAChR) |
| 02/20/2013 | EP2558120A1 Methods and compositions for intranasal delivery |
| 02/20/2013 | EP2558108A1 Iron oxide nanoparticles for use in treating non-infectious inflammatory disorders |
| 02/20/2013 | EP2558107A2 Compositions with reactive ingredients, and wound dressings, apparatuses, and methods |
| 02/20/2013 | EP2558106A1 Methods and compositions for improving implant osseointegration |
| 02/20/2013 | EP2558104A1 Method and ophthalmic composition for treating retinal disease |
| 02/20/2013 | EP2558090A1 Radiation sensitiser compositions |
| 02/20/2013 | EP2558088A1 Polymer composition with phytochemical and dialysis membrane formed from the polymer composition |
| 02/20/2013 | EP2558086A1 Homeopathic medicament comprising phenacetin for the treatment of cancer |
| 02/20/2013 | EP2558081A2 Intraocular pressure reduction with intracameral bimatoprost implants |
| 02/20/2013 | EP2558080A2 Improvements relating to antiviral compositions |
| 02/20/2013 | EP2558079A1 Ciprofloxacin dry syrup composition |
| 02/20/2013 | EP2558078A2 Anti-abuse pharmaceutical compositions |
| 02/20/2013 | EP2558077A2 Oral pharmaceutical composition comprising fenofibric acid and an alkalifying agent |
| 02/20/2013 | EP2558075A1 Compoisitons comprising polyglutamic acid nanoparticles and polypeptides such as cd40 agonists |
| 02/20/2013 | EP2558074A1 Preparation of lipid nanoparticles |
| 02/20/2013 | EP2558073A1 Oral testosterone ester formulations and methods of treating testoterone deficiency comprising same |
| 02/20/2013 | EP2558072A1 Prodrug compositions, prodrug nanoparticles, and methods of use thereof |
| 02/20/2013 | EP2558071A2 Stable liquid oily ready-to-use formulations, preparation thereof and use thereof |
| 02/20/2013 | EP2558070A1 Acetaminophen composition |
| 02/20/2013 | EP2558069A1 Benzonapthyridine compositions and uses thereof |
| 02/20/2013 | EP2558068A2 Anti-abuse gelled pharmaceutical compositions |
| 02/20/2013 | EP2558067A2 Compounds, compositions, and methods for reducing or eliminating bitter taste |
| 02/20/2013 | EP2558066A1 Effervescent tablets comprising an oil component |
| 02/20/2013 | EP2558065A1 Effervescent pharmaceutical compositions containing n-acetylcysteine |
| 02/20/2013 | EP2558064A2 Oral pharmaceutical dispersion compositions |
| 02/20/2013 | EP2558063A1 Very low-dosed solid oral dosage forms for hrt |
| 02/20/2013 | EP2557943A2 Oral veterinary pharmaceutical and nutraceutical compositions |
| 02/20/2013 | EP2557924A1 Dermal pharmaceutical compositions of 1-methyl-2',6'-pipecoloxylidide and method of use |
| 02/20/2013 | EP2557919A1 Stabilized statin formulations |
| 02/20/2013 | EP2557918A2 Methods for increasing effectiveness of antimicrobial agents in polymeric films |
| 02/20/2013 | CN202740435U Plaster |
| 02/20/2013 | CN202740434U Plaster patch |
| 02/20/2013 | CN102939111A Process for preparing an immunoglobulin composition |
| 02/20/2013 | CN102939107A Antibody preparations |
| 02/20/2013 | CN102939106A Protein formulations |
| 02/20/2013 | CN102939091A Pharmaceutical composition and use thereof in manufacturing medicaments for treating respiratory diseases |
| 02/20/2013 | CN102939079A Thermally stable oil-in-water emulsions containing an oil that contains polyunsaturated fatty acids |
| 02/20/2013 | CN102939078A A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid |
| 02/20/2013 | CN102939077A Nanoemulsion composition containing vitamin k |
| 02/20/2013 | CN102939076A Chitosan |
| 02/20/2013 | CN102939075A Transdermal absorption promoter, and external skin formulation thereof |
| 02/20/2013 | CN102939074A Stabilized ophthalmic galactomannan formulations |
| 02/20/2013 | CN102939073A Composition for use as an assay reagent |
| 02/20/2013 | CN102936475A Carrier adhesive for plasters and patches and preparation method thereof |
| 02/20/2013 | CN102935235A Preparation method of modified casein drug-carrying controlled-release thin film |
| 02/20/2013 | CN102935234A Film coating medicine and preparation method thereof |
| 02/20/2013 | CN102935232A Production and application methods of magnesium-stearate-containing medicinal premix auxiliary material used in direct tableting or capsule filling |
| 02/20/2013 | CN102935224A Medicinal extract ointment for treating skin scald |
| 02/20/2013 | CN102935221A Anti-aging tablet |
| 02/20/2013 | CN102935213A Preparation method of ointment for improving skin itch of urogenital canal |
| 02/20/2013 | CN102935210A Method for preparing blood-activating and tissue regeneration-promoting ointment and blood-activating and tissue regeneration-promoting ointment |
| 02/20/2013 | CN102935207A Cataplasm for treating early chiblain and method for preparing same |
| 02/20/2013 | CN102935185A Pills for treating neurasthenia and preparation method |
| 02/20/2013 | CN102935176A Buccal granules for chronic pharyngolaryngitis and preparation method |
| 02/20/2013 | CN102935171A Aerosol for treating recurrent oral ulceration and preparation process of aerosol |
| 02/20/2013 | CN102935164A Traditional Chinese medicinal capsule for treating menstrual disorder and method for preparing same |
| 02/20/2013 | CN102935160A Traditional Chinese medicine cataplasm for improving intestines and stomach functions and preparation method thereof |
| 02/20/2013 | CN102935157A Chinese medicinal ointment for treating closed fracture |
| 02/20/2013 | CN102935156A Pills for treating hyperostosis |
| 02/20/2013 | CN102935153A Qi reinforcing qianzheng pills for cerebral thrombosis disease treatment |
| 02/20/2013 | CN102935150A Preparation method of apocynum venetum antihypertensive effervescent tablet |
| 02/20/2013 | CN102935147A Chinese patent medicinal gastric floating tablet for treating gastrorrhagia and method for preparing same |
| 02/20/2013 | CN102935143A Preparation method for compound traditional Chinese medicine preparation children common cold granules |
| 02/20/2013 | CN102935134A Cooling paste for child and preparation method thereof |
| 02/20/2013 | CN102935122A Antidiarrheal particle and preparation method thereof |
| 02/20/2013 | CN102935119A Method for preparing ointment for treating lumbar disc herniation |
| 02/20/2013 | CN102935113A Preparation method for Shuanghuanglian granules |
| 02/20/2013 | CN102935110A Coated granules containing natural oregano oil for birds and preparation method thereof |
| 02/20/2013 | CN102935108A Pollen pini water extract enteric-coated tablet for alleviating hangovers |
| 02/20/2013 | CN102935105A Pollen pini water extract enteric-coated tablet for preventing alcoholic fatty liver (AFL) |
| 02/20/2013 | CN102935103A Preparation method for effervescent tablet containing pueraria mirifica flavone |
| 02/20/2013 | CN102935087A Compound electrolyte injection composition and preparation method thereof |
| 02/20/2013 | CN102935086A Calcium tablet |
| 02/20/2013 | CN102935084A Compound ivermectin sustained release tablet and preparation method thereof |
| 02/20/2013 | CN102935078A Ibuprofen oral dispersing film agent |